Research Progress in the Treatment of Human Cytomegalovirus Infection
10.3870/j.issn.1004-0781.2025.08.015
- VernacularTitle:人巨细胞病毒感染治疗的研究进展
- Author:
Jianfeng WANG
1
;
Zhenjun LIU
1
Author Information
1. 安庆市立医院感染性疾病科,安庆 246003
- Publication Type:Journal Article
- Keywords:
Antiviral drugs;
Human cytomegalovirus;
Vaccines;
Immunoglobulins;
Drug resistance
- From:
Herald of Medicine
2025;44(8):1289-1296
- CountryChina
- Language:Chinese
-
Abstract:
Human cytomegalovirus(HCMV)infection can manifest as asymptomatic,systemic symptoms or tissue invasive disease,etc.After infection,it can establish a persistent or latent infection in the host,and viral reactivation occurs in the case of immunocompromised organisms and leads to serious diseases.With the widespread use of antiviral drugs,the prognosis of HCMV infection has been improved,but long-term antiviral therapy is accompanied by the emergence of adverse drug reactions or drug resistance,and refractory or drug-resistant HCMV infections have become a clinical problem which should not be ignored and solved urgently.Therefore,this article reviews the latest advances of treatment strategies for HCMV infection for clinical reference.
